Clinical trials: Method of Differentiating Benignancy and Malignancy, Grading and Staging for GIST
Method of Differentiating Benignancy and Malignancy, Grading and Staging for GIST
Study to Compare Pathologic Type, NIH and WHO Criteria,and Mechanism of GIST Malignant Transformation
Evaluate the reliability of morphology standards for GIST pathologic type, staging and grading by retrospective analyzing clinical data; on this basis, establish a GIST standardized and individualized treatment mode to maximum…
- Trial name
- NCT03381053
- Testing
- Imatinib 400mg
- Where
- China
- Volunteers
- 3,000 people
- Sponsor
- Shanghai Zhongshan Hospital